Cargando…

Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma

INTRODUCTION: We assessed the profile and frequency of malignancy subtypes in a large single-centre UK cohort for patients with scleroderma (systemic sclerosis; SSc). We evaluated the cancer risk among SSc patients with different antibody reactivities and explored the temporal association of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moinzadeh, Pia, Fonseca, Carmen, Hellmich, Martin, Shah, Ami A, Chighizola, Cecilia, Denton, Christopher P, Ong, Voon H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978927/ https://www.ncbi.nlm.nih.gov/pubmed/24524733 http://dx.doi.org/10.1186/ar4486

Ejemplares similares

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Pharmacology and rationale for imatinib in the treatment of scleroderma
por: Moinzadeh, Pia, et al.
Publicado: (2013)

Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts
por: Raschi, Elena, et al.
Publicado: (2018)

A Unique Presentation of Anti-RNA Polymerase III Positive Systemic Sclerosis Sine Scleroderma
por: Lee, Cody M., et al.
Publicado: (2016)

A Rare Case of Cardiac Tamponade in a Patient With Anti-RNA Polymerase III Scleroderma
por: Schneider, Artur, et al.
Publicado: (2023)

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
por: Raschi, Elena, et al.
Publicado: (2020)

A Case of Renal Crisis in a Korean Scleroderma Patient with Anti-RNA polymerase I and III Antibodies
por: Kang, Eun Ha, et al.
Publicado: (2006)

The clinical relevance of autoantibodies in scleroderma
por: Ho, Khanh T, et al.
Publicado: (2003)

Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature
por: Derrett-Smith, Emma C., et al.
Publicado: (2017)

Atypical clinical presentation of a subset of patients with anti-RNA polymerase III - non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining
por: Ceribelli, Angela, et al.
Publicado: (2011)

Clinical phenotype in scleroderma patients based on autoantibodies
por: Santos, Cristiana Sieiro, et al.
Publicado: (2023)

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features
por: Mierau, Rudolf, et al.
Publicado: (2011)

Systemic Sclerosis Sine Scleroderma Manifested with Gastrointestinal Bleeding, Antiphospholipid Syndrome and Positive Anti-RNA Polymerase III Antibody: Case Report and Literature Review
por: Alghamdi, Mansour, et al.
Publicado: (2020)

Association of Silicone Breast Implants, Breast Cancer and Anti-RNA Polymerase III Autoantibodies in Systemic Sclerosis: Case-Based Review
por: De Angelis, Rossella, et al.
Publicado: (2020)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer
por: Betteridge, Zoe E., et al.
Publicado: (2018)

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
por: Clark, Kristina Elizabeth Neergaard, et al.
Publicado: (2023)

Prevalence of anti-histone antibodies, their clinical significance and correlation with other autoantibodies in a cohort of Italian scleroderma patients
por: Morozzi, Gabriella, et al.
Publicado: (2011)

Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells
por: Gilbane, Adrian J, et al.
Publicado: (2013)

Prevalence and Clinical Implications of Scleroderma-Specific Autoantibodies in Seronegative Patients with Sicca Complaints
por: Marketos, Nikolaos, et al.
Publicado: (2023)

Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus
por: Azzouz, Doua F., et al.
Publicado: (2016)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry
por: Gourh, Pravitt, et al.
Publicado: (2020)

What autoantibody tests should become widely available to help scleroderma diagnosis and management?
por: Muro, Yoshinao, et al.
Publicado: (2013)

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
por: Caetano, Joana, et al.
Publicado: (2018)

Race and Association With Disease Manifestations and Mortality in Scleroderma: A 20-Year Experience at the Johns Hopkins Scleroderma Center and Review of the Literature
por: Gelber, Allan C., et al.
Publicado: (2013)

Recruitment of RNA polymerase III in vivo
por: Kenneth, Niall S., et al.
Publicado: (2008)

Structure of human RNA polymerase III
por: Ramsay, Ewan Phillip, et al.
Publicado: (2020)

RNA Polymerase III, Ageing and Longevity
por: Kulaberoglu, Yavuz, et al.
Publicado: (2021)

Inhibition of RNA Polymerase III Augments the Anti-Cancer Properties of TNFα
por: Nair, Hitha Gopalan, et al.
Publicado: (2023)

Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients
Publicado: (1981)

Extragenic Accumulation of RNA Polymerase II Enhances Transcription by RNA Polymerase III
por: Listerman, Imke, et al.
Publicado: (2007)

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis
por: Cantanhede, Isabella Gomes, et al.
Publicado: (2022)

Lymphatic and blood vessels in scleroderma skin, a morphometric analysis
por: Rossi, Antonella, et al.
Publicado: (2010)

Hand disease in scleroderma: a clinical correlate for chronic hand transplant rejection
por: Amin, Kavit, et al.
Publicado: (2013)

Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of scleroderma
por: Derrett-Smith, Emma C, et al.
Publicado: (2010)

Sixth International Workshop on Scleroderma Research, Oxford, UK, 30 July–2 August 2000
por: Wollheim, Frank A, et al.
Publicado: (2001)

Antitopoisomerase I monoclonal autoantibodies from scleroderma patients and tight skin mouse interact with similar epitopes
Publicado: (1992)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sqn8ovdcem1uj8lcv8t4v5u60s